ADVFN - ニュース

S&P 500

5,619.42

-0.24%

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/18	04 : 21	PR Newswire (Canada)	Négociations dans le secteur public - Les membres de la FIQ se prononceront sur la recommandation du conciliateur
2024/09/18	04 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ESPR	Esperion Therapeutics Inc
2024/09/18	04 : 19	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXZ	iPath Series B S&P 500 VIX MidTerm Futures ETN
2024/09/18	04 : 19	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BACRP	Bank of America Corp (PK)
2024/09/18	04 : 19	PR Newswire (US)	Automated Ad Design Tool BannersUI Available for DAM Integration & via BrandingUI
2024/09/18	04 : 19	PR Newswire (Canada)	Statement - Death of an inmate from Archambault Institution
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:UFPI	UFP Industries Inc
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 18	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXZ	iPath Series B S&P 500 VIX MidTerm Futures ETN
2024/09/18	04 : 18	PR Newswire (Canada)	New EAM-Mosca Unitizer Max-Core Answers End of Line Load and Pallet Strapping Needs
2024/09/18	04 : 18	PR Newswire (US)	SAFCO Welcomes Noel Ortega As Its New SVP of Account Services
2024/09/18	04 : 18	PR Newswire (US)	New EAM-Mosca Unitizer Max-Core Answers End of Line Load and Pallet Strapping Needs
2024/09/18	04 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/09/18	04 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:BHB	Bar Harbor Bankshares
2024/09/18	04 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:BHB	Bar Harbor Bankshares
2024/09/18	04 : 17	Business Wire	Reveal lance officiellement sa plateforme Logikcull dans toute l'Europe
2024/09/18	04 : 17	PR Newswire (Canada)	B.C. forestry unions come together to "fight for our future" at UBCM
2024/09/18	04 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EL	Estee Lauder Companies Inc
2024/09/18	04 : 16	Business Wire	Reveal veröffentlicht seine Logikcull-Plattform offiziell in ganz Europa
2024/09/18	04 : 16	PR Newswire (US)	Legado Capital Advisors launches new Investment Banking and ABS Advisory Practice headed by Victor Mendoza
2024/09/18	04 : 15	Alliance News	IN BRIEF: Merck and Daiichi Sankyo's patritumab effective in phase 3	TG:D4S	Daiichi Sankyo Co Ltd
2024/09/18	04 : 15	Alliance News	IN BRIEF: Merck and Daiichi Sankyo's patritumab effective in phase 3	LSE:0QAH	Merck & Co Inc